Tenofovir for children and adults with chronic hepatitis B

Huijuan Li; Minyan Yang; Mina Ma; Zijun Li; Meixuan Li; Long Dong Zhu; Liang Yao; Junfeng Li; Linda Zhong; Kehu Yang

doi:10.1002/14651858.CD015586

Tenofovir for children and adults with chronic hepatitis B

Huijuan Li, Minyan Yang, Mina Ma, Zijun Li, Meixuan Li, Long Dong Zhu, Liang Yao, Junfeng Li, Linda Zhong, Kehu Yang^*

^*Corresponding author for this work

Chinese Medicine - Teaching and Research Division

Research output: Contribution to journal › Journal article › peer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of tenofovir versus no intervention or placebo for children and adults with chronic hepatitis B.

Original language	English
Article number	CD015586
Number of pages	19
Journal	Cochrane Database of Systematic Reviews
Volume	2023
Issue number	9
DOIs	https://doi.org/10.1002/14651858.CD015586
Publication status	Published - 8 Sept 2023

Scopus Subject Areas

Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/14651858.CD015586

Cite this

@article{195ed51c20d047039ab9a4aea6e4e37a,

title = "Tenofovir for children and adults with chronic hepatitis B",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of tenofovir versus no intervention or placebo for children and adults with chronic hepatitis B.",

author = "Huijuan Li and Minyan Yang and Mina Ma and Zijun Li and Meixuan Li and Zhu, {Long Dong} and Liang Yao and Junfeng Li and Linda Zhong and Kehu Yang",

note = "Publisher Copyright: Copyright {\textcopyright} 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2023",

month = sep,

day = "8",

doi = "10.1002/14651858.CD015586",

language = "English",

volume = "2023",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley & Sons Ltd.",

number = "9",

}

TY - JOUR

T1 - Tenofovir for children and adults with chronic hepatitis B

AU - Li, Huijuan

AU - Yang, Minyan

AU - Ma, Mina

AU - Li, Zijun

AU - Li, Meixuan

AU - Zhu, Long Dong

AU - Yao, Liang

AU - Li, Junfeng

AU - Zhong, Linda

AU - Yang, Kehu

PY - 2023/9/8

Y1 - 2023/9/8

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of tenofovir versus no intervention or placebo for children and adults with chronic hepatitis B.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of tenofovir versus no intervention or placebo for children and adults with chronic hepatitis B.

UR - http://www.scopus.com/inward/record.url?scp=85171837437&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD015586

DO - 10.1002/14651858.CD015586

M3 - Journal article

AN - SCOPUS:85171837437

SN - 1465-1858

VL - 2023

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 9

M1 - CD015586

ER -

Tenofovir for children and adults with chronic hepatitis B

Abstract

Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Cite this